What Wall Street Analysts Are Buzzing About This Morning

London Trading Floor Bankers Traders

Photo: Peter Macdiarmid/Getty

Good morning. Here’s your daily equity research roundup from the Street.Morgan Stanley:

Apple (AAPL): Morgan Stanley analysts Kathryn Huberty and Jerry Liu reiterate their Overweight rating and $720 price target on AAPL, writing that “New data from Apple’s 10-Q suggests potentially better than expected C3Q results and, more importantly, strong product momentum heading into iPhone 5 and iPad Mini launches.”


The New York Times (NYT): Barclays analyst Kannan Venkateshwar is raising his price target on NYT to $9 from $8, giving three reasons: “1) Given lower cyclicality of circulation revenues relative to advertising revenues, we expect earnings volatility to reduce across cycles; 2) An increasing proportion of digital circulation revenues and continued drop in print is likely to be positive for margins; 3) NYT likely to start returning cash to shareholders near term.”


The Coca-Cola Company (KO): Citi analyst Wendy Nicholson is lifting her price target on KO to $91 from $88, writing that “we still consider KO’s current valuation of 18x our 2013 EPS estimate to be attractive given the confidence we have in KO’s long-term growth story.”

Credit Suisse:

Humana (HUM): Credit Suisse is lowering its price target on HUM after the company reported earnings, saying, “the individual Medicare Advantage business slightly missed our forecast.”

SEE ALSO: Here’s what the largest companies are telling us about the state of the economy >

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.